Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
338.60
+3.08 (0.92%)
Sep 11, 2025, 2:52 PM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $289.56 billion as of September 11, 2025. Its market cap has increased by 7.67% in one year.
Market Cap
289.56B
Enterprise Value
323.45B
Revenue
79.83B
Ranking
n/a
PE Ratio
24.42
Stock Price
$338.60
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 289.56B, an increase of 3,205.95%. That is a compound annual growth rate of 10.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2025 | 286.55B | 26.67% |
Dec 30, 2024 | 226.23B | -3.34% |
Dec 29, 2023 | 234.04B | -9.76% |
Dec 30, 2022 | 259.35B | -22.73% |
Dec 30, 2021 | 335.62B | 12.23% |
Dec 30, 2020 | 299.05B | 8.13% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 781.22M |
Elite Pharmaceuticals | 736.80M |
Tian'an Technology Group | 732.84M |
Glass House Brands | 577.09M |
Northwest Biotherapeutics | 376.88M |
CytoDyn | 367.97M |
American Oncology Network | 346.29M |